Intellia Therapeutics, Inc. 4
4 · Intellia Therapeutics, Inc. · Filed Jun 5, 2017
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2017-06-02$12.37/sh+8,400$103,938→ 8,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.25 to $12.49, inclusive.